These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 34259944)

  • 1. The Role of Antiphospholipid Antibodies in COVID-19.
    Stelzer M; Henes J; Saur S
    Curr Rheumatol Rep; 2021 Jul; 23(9):72. PubMed ID: 34259944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiphospholipid antibodies in patients with COVID-19: A relevant observation?
    Devreese KMJ; Linskens EA; Benoit D; Peperstraete H
    J Thromb Haemost; 2020 Sep; 18(9):2191-2201. PubMed ID: 32619328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic Review of Antiphospholipid Antibodies in COVID-19 Patients: Culprits or Bystanders?
    Foret T; Dufrost V; Salomon Du Mont L; Costa P; Lefevre B; Lacolley P; Regnault V; Zuily S; Wahl D
    Curr Rheumatol Rep; 2021 Jul; 23(8):65. PubMed ID: 34218350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of anti-domain 1 β2-glycoprotein I antibodies in antiphospholipid syndrome.
    Iwaniec T; Kaczor MP; Celińska-Löwenhoff M; Polański S; Musiał J
    Thromb Res; 2017 May; 153():90-94. PubMed ID: 28363116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reality Check on Antiphospholipid Antibodies in COVID-19-Associated Coagulopathy.
    Gkrouzman E; Barbhaiya M; Erkan D; Lockshin MD
    Arthritis Rheumatol; 2021 Jan; 73(1):173-174. PubMed ID: 32901454
    [No Abstract]   [Full Text] [Related]  

  • 6. Antiphospholipid syndrome: critical analysis of the diagnostic path.
    Pengo V; Banzato A; Bison E; Denas G; Padayattil Jose S; Ruffatti A
    Lupus; 2010 Apr; 19(4):428-31. PubMed ID: 20353982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibody explosion in antiphospholipid syndrome.
    Shoenfeld Y; Twig G; Katz U; Sherer Y
    J Autoimmun; 2008; 30(1-2):74-83. PubMed ID: 18171610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-annexin A5 antibodies and 25-hydroxy-cholecalciferol in female patients with primary antiphospholipid syndrome.
    Bećarević M; Sarić M; Stojanovich L; Mirković D; Dopsaj V; Ignjatović S
    Clin Rheumatol; 2018 Dec; 37(12):3359-3364. PubMed ID: 29948348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
    Day HM; Thiagarajan P; Ahn C; Reveille JD; Tinker KF; Arnett FC
    J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laboratory evaluation of anti-phospholipid syndrome: a preliminary prospective study of phosphatidylserine/prothrombin antibodies in an at-risk patient cohort.
    Heikal NM; Jaskowski TD; Malmberg E; Lakos G; Branch DW; Tebo AE
    Clin Exp Immunol; 2015 May; 180(2):218-26. PubMed ID: 25522978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interest of IgG and IgM antiprothrombin autoantibodies in the exploration of antiphospholipid syndrome: a 5-year retrospective study.
    Bertin D; Beziane A; Resseguier N; Pelissier M; Morange PE; Mege JL; Bardin N
    Rheumatology (Oxford); 2020 Jul; 59(7):1539-1544. PubMed ID: 31630203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiphospholipid patterns predict risk of thrombosis in systemic lupus erythematosus.
    Demir S; Li J; Magder LS; Petri M
    Rheumatology (Oxford); 2021 Aug; 60(8):3770-3777. PubMed ID: 33331921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency of positive antiphospholipid antibodies in pregnant women with SARS-CoV-2 infection and impact on pregnancy outcome: A single-center prospective study on 151 pregnancies.
    Gozzoli GI; Piovani E; Negri B; Mascherpa M; Orabona R; Zanardini C; Zatti S; Piantoni S; Lazzaroni MG; Tomasi C; Prefumo F; Sartori E; Franceschini F; Tincani A; Andreoli L
    Front Immunol; 2022; 13():953043. PubMed ID: 36189273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between cardiac manifestations and antiphospholipid antibody type and level in a cohort of Serbian patients with primary and secondary antiphospholipid syndrome.
    Djokovic A; Stojanovich L; Kontic M; Stanisavljevic N; Radovanovic S; Marisavljevic D
    Isr Med Assoc J; 2014 Mar; 16(3):162-7. PubMed ID: 24761704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The estimated frequency of antiphospholipid antibodies in young adults with cerebrovascular events: a systematic review.
    Sciascia S; Sanna G; Khamashta MA; Cuadrado MJ; Erkan D; Andreoli L; Bertolaccini ML;
    Ann Rheum Dis; 2015 Nov; 74(11):2028-33. PubMed ID: 24942381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is There an Additional Value in Detecting Anticardiolipin and Anti-β2 glycoprotein I IgA Antibodies in the Antiphospholipid Syndrome?
    Chayoua W; Yin DM; Kelchtermans H; Moore GW; Gris JC; Musiał J; Zuily S; Ten Cate H; de Laat B; Devreese KMJ
    Thromb Haemost; 2020 Nov; 120(11):1557-1568. PubMed ID: 32696448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current clinical and laboratory practice for the investigation of the antiphospholipid syndrome: findings from the 2008 Australasian antiphospholipid antibody survey.
    Favaloro EJ; Wong RC
    Pathology; 2009; 41(7):666-75. PubMed ID: 20001347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency and clinical correlates of antiphospholipid antibodies arising in patients with SARS-CoV-2 infection: findings from a multicentre study on 122 cases.
    Gatto M; Perricone C; Tonello M; Bistoni O; Cattelan AM; Bursi R; Cafaro G; De Robertis E; Mencacci A; Bozza S; Vianello A; Iaccarino L; Gerli R; Doria A; Bartoloni E
    Clin Exp Rheumatol; 2020; 38(4):754-759. PubMed ID: 32723434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A retrospective study on the prevalence of anti-phospholipid antibodies, thrombotic events and cutaneous signs of vasculopathy in 173 hospitalized COVID-19 patients.
    Gasparini G; Canepa P; Verdiani S; Carmisciano L; Cozzani E; De Grazia D; Andrea O; Icardi G; Parodi A
    Int J Immunopathol Pharmacol; 2021; 35():20587384211042115. PubMed ID: 34541915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19 and Antiphospholipid Antibodies: Time for a Reality Check?
    Favaloro EJ; Henry BM; Lippi G
    Semin Thromb Hemost; 2022 Feb; 48(1):72-92. PubMed ID: 34130340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.